PETALING JAYA: Out of over 65 million doses of Covid-19 vaccines administered nationwide, a total of 25,211 adverse event following immunisation (AEFI) reports have been received by the National Pharmaceutical Regulatory Agency (NPRA) up to Feb 18.

       NPRA director Dr Roshayati Mohamad Sani said this included 1,186 AEFIs from booster doses.

       A total of 93% of overall AEFI reports or 23,453 cases were categorised as not serious while 1,758 AEFI reports were classified as serious, she added.

       “Non-serious AEFIs are usually resolved within one or two days. Examples of non-serious AEFIs include fever, pain at the injection site, headache, muscle ache and fatigue,” she told the media at a Covid-19 vaccine AEFI report briefing session on Wednesday (Feb 23).

       Meanwhile, serious AEFIs were classified as cases with effects requiring hospitalisation, prolonged stays in the ward, life-threatening symptoms and those suspected to have resulted in death.

       As of Feb 18, a total of 65,777,392 doses of Covid-19 vaccines have been administered including 13,768,697 booster doses.